Arvinas (ARVN) EBITDA Margin Growth (1y) (2018 - 2026)
Arvinas (ARVN) EBITDA Margin Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Arvinas |
492.16 Mn |
-122.74 Mn |
- |
-42,366.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-42,366.00 |
| Dec 31, 2025 |
-63,016.00 |
| Sep 30, 2025 |
-4,248.00 |
| Jun 30, 2025 |
-23,022.00 |
| Mar 31, 2025 |
32,362.00 |
| Dec 31, 2024 |
-42,643.00 |
| Sep 30, 2024 |
13,597.00 |
| Jun 30, 2024 |
7,624.00 |
| Mar 31, 2024 |
-4,775.00 |
| Dec 31, 2023 |
54,924.00 |
| Sep 30, 2023 |
3,153.00 |
| Jun 30, 2023 |
9,540.00 |
| Mar 31, 2023 |
6,076.00 |
| Dec 31, 2022 |
-3,255.00 |
| Sep 30, 2022 |
29,647.00 |
| Jun 30, 2022 |
70,132.00 |
| Mar 31, 2022 |
46,755.00 |
| Dec 31, 2021 |
44,827.00 |
| Sep 30, 2021 |
-8,639.00 |
| Jun 30, 2021 |
-45,741.00 |
